OMER

Omeros (OMER)

Omeros Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OMER

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	05 : 09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMER	Omeros Corporation
2024/05/16	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2024/05/16	05 : 02	Business Wire	Omeros Corporation Reports First Quarter 2024 Financial Results	NASDAQ:OMER	Omeros Corporation
2024/05/10	21 : 50	Business Wire	Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024	NASDAQ:OMER	Omeros Corporation
2024/05/09	21 : 50	Business Wire	Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress	NASDAQ:OMER	Omeros Corporation
2024/04/02	05 : 02	Business Wire	Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results	NASDAQ:OMER	Omeros Corporation
2024/03/27	21 : 30	Business Wire	Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024	NASDAQ:OMER	Omeros Corporation
2024/02/20	23 : 00	Business Wire	Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	NASDAQ:OMER	Omeros Corporation
2024/02/14	20 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OMER	Omeros Corporation
2024/02/07	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2024/02/01	23 : 11	Business Wire	Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust	NASDAQ:OMER	Omeros Corporation
2024/01/30	05 : 26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:OMER	Omeros Corporation
2023/11/22	10 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/16	11 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/10	06 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMER	Omeros Corporation
2023/11/10	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2023/11/10	06 : 02	Business Wire	Omeros Corporation Reports Third Quarter 2023 Financial Results	NASDAQ:OMER	Omeros Corporation
2023/11/06	22 : 00	Business Wire	Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023	NASDAQ:OMER	Omeros Corporation
2023/11/03	22 : 05	Business Wire	Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	NASDAQ:OMER	Omeros Corporation
2023/11/02	22 : 05	Business Wire	Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting	NASDAQ:OMER	Omeros Corporation
2023/10/19	21 : 30	Business Wire	Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer	NASDAQ:OMER	Omeros Corporation
2023/10/17	05 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2023/10/16	20 : 30	Business Wire	Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy	NASDAQ:OMER	Omeros Corporation
2023/09/28	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/28	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/28	05 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/21	05 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OMER	Omeros Corporation